These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33143788)

  • 1. Clinicopathological investigation of the background of cognitive decline in elderly schizophrenia.
    Miwa A; Hirano M; Torii Y; Sekiguchi H; Habuchi C; Fujishiro H; Yoshida M; Iwai K; Kawashima K; Iritani S
    Acta Neuropsychiatr; 2021 Apr; 33(2):85-91. PubMed ID: 33143788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
    Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
    Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathology and cognitive performance in self-reported cognitively healthy centenarians.
    Ganz AB; Beker N; Hulsman M; Sikkes S; Netherlands Brain Bank ; Scheltens P; Smit AB; Rozemuller AJM; Hoozemans JJM; Holstege H
    Acta Neuropathol Commun; 2018 Jul; 6(1):64. PubMed ID: 30037350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the identification of dementia with Lewy bodies in the context of an Alzheimer's-type dementia.
    Thomas AJ; Mahin-Babaei F; Saidi M; Lett D; Taylor JP; Walker L; Attems J
    Alzheimers Res Ther; 2018 Mar; 10(1):27. PubMed ID: 29490691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant Overlap of α-Synuclein, Amyloid-β, and Phospho-Tau Pathologies in Neuropathological Diagnosis of Lewy-related Pathology: Evidence from China Human Brain Bank.
    Cong C; Zhang W; Qian X; Qiu W; Ma C
    J Alzheimers Dis; 2021; 80(1):447-458. PubMed ID: 33554920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline.
    Clinton LK; Blurton-Jones M; Myczek K; Trojanowski JQ; LaFerla FM
    J Neurosci; 2010 May; 30(21):7281-9. PubMed ID: 20505094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Background of the neuropathological site in neurocognitive decline in elderly schizophrenic patients.
    Hirano M; Iritani S; Sekiguchi H; Torii Y; Habuchi C; Fujishiro H; Ozaki N; Yoshida M; Fujita K
    Psychogeriatrics; 2020 Jul; 20(4):522-527. PubMed ID: 31994823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.
    Walker L; McAleese KE; Thomas AJ; Johnson M; Martin-Ruiz C; Parker C; Colloby SJ; Jellinger K; Attems J
    Acta Neuropathol; 2015 May; 129(5):729-48. PubMed ID: 25758940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed pathologies including chronic traumatic encephalopathy account for dementia in retired association football (soccer) players.
    Ling H; Morris HR; Neal JW; Lees AJ; Hardy J; Holton JL; Revesz T; Williams DD
    Acta Neuropathol; 2017 Mar; 133(3):337-352. PubMed ID: 28205009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. I716F AβPP mutation associates with the deposition of oligomeric pyroglutamate amyloid-β and α-synucleinopathy with Lewy bodies.
    Sieczkowski E; Milenkovic I; Venkataramani V; Giera R; Ströbel T; Höftberger R; Liberski PP; Auff E; Wirths O; Bayer TA; Kovacs GG
    J Alzheimers Dis; 2015; 44(1):103-14. PubMed ID: 25182745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer-type neuropathology in elderly schizophrenia patients.
    Prohovnik I; Dwork AJ; Kaufman MA; Willson N
    Schizophr Bull; 1993; 19(4):805-16. PubMed ID: 8303229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limbic neuropathology in idiopathic Parkinson's disease with concomitant dementia.
    Bertrand E; Lechowicz W; Szpak GM; Lewandowska E; Dymecki J; Wierzba-Bobrowicz T
    Folia Neuropathol; 2004; 42(3):141-50. PubMed ID: 15535032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases.
    Purohit DP; Perl DP; Haroutunian V; Powchik P; Davidson M; Davis KL
    Arch Gen Psychiatry; 1998 Mar; 55(3):205-11. PubMed ID: 9510214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients.
    Daniele S; Baldacci F; Piccarducci R; Palermo G; Giampietri L; Manca ML; Pietrobono D; Frosini D; Nicoletti V; Tognoni G; Giorgi FS; Lo Gerfo A; Petrozzi L; Cavallini C; Franzoni F; Ceravolo R; Siciliano G; Trincavelli ML; Martini C; Bonuccelli U
    J Alzheimers Dis; 2021; 80(2):885-893. PubMed ID: 33579836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiety symptoms are quantitatively and qualitatively different in dementia with Lewy bodies than in Alzheimer's disease in the years preceding clinical diagnosis.
    Segers K; Benoit F; Meyts JM; Surquin M
    Psychogeriatrics; 2020 May; 20(3):242-246. PubMed ID: 31782249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Cortical β-Amyloid Protein in the Absence of Insoluble Deposits With Alzheimer Disease.
    Yu L; Petyuk VA; Tasaki S; Boyle PA; Gaiteri C; Schneider JA; De Jager PL; Bennett DA
    JAMA Neurol; 2019 Jul; 76(7):818-826. PubMed ID: 31009033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age.
    Betthauser TJ; Koscik RL; Jonaitis EM; Allison SL; Cody KA; Erickson CM; Rowley HA; Stone CK; Mueller KD; Clark LR; Carlsson CM; Chin NA; Asthana S; Christian BT; Johnson SC
    Brain; 2020 Jan; 143(1):320-335. PubMed ID: 31886494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration.
    Chai YL; Chong JR; Weng J; Howlett D; Halsey A; Lee JH; Attems J; Aarsland D; Francis PT; Chen CP; Lai MKP
    Brain Pathol; 2019 Jan; 29(1):63-74. PubMed ID: 30051532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders.
    Coughlin D; Xie SX; Liang M; Williams A; Peterson C; Weintraub D; McMillan CT; Wolk DA; Akhtar RS; Hurtig HI; Branch Coslett H; Hamilton RH; Siderowf AD; Duda JE; Rascovsky K; Lee EB; Lee VM; Grossman M; Trojanowski JQ; Irwin DJ
    Ann Neurol; 2019 Feb; 85(2):259-271. PubMed ID: 30549331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological Correlates of Cognitive Impairment in The University of Manchester Longitudinal Study of Cognition in Normal Healthy Old Age.
    Robinson AC; Davidson YS; Horan MA; Pendleton N; Mann DMA
    J Alzheimers Dis; 2018; 64(2):483-496. PubMed ID: 29865073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.